메뉴 건너뛰기




Volumn 250, Issue , 2013, Pages 507-519

The vesicular monoamine transporter (VMAT-2) inhibitor tetrabenazine induces tremulous jaw movements in rodents: Implications for pharmacological models of parkinsonian tremor

Author keywords

Adenosine; C Fos; Dopamine; Huntington's; Parkinson's; Tremor

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 2A ADRENERGIC RECEPTOR; MSX 3; PROTEIN C FOS; TETRABENAZINE; UNCLASSIFIED DRUG; VESICULAR MONOAMINE TRANSPORTER 2;

EID: 84882788730     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2013.07.008     Document Type: Article
Times cited : (20)

References (113)
  • 1
    • 0142091310 scopus 로고    scopus 로고
    • Cognitive, psychiatric and motor response to galantamine in Parkinson's disease with dementia
    • Aarsland D., Hutchison M., Larsen J.P. Cognitive, psychiatric and motor response to galantamine in Parkinson's disease with dementia. Int J Geriat Psychiat 2003, 18:937-941.
    • (2003) Int J Geriat Psychiat , vol.18 , pp. 937-941
    • Aarsland, D.1    Hutchison, M.2    Larsen, J.P.3
  • 3
    • 0033566277 scopus 로고    scopus 로고
    • Region-specific induction of deltaFosB by repeated administration of typical versus atypical antipsychotic drugs
    • Atkins J.B., Chlan-Fourney J., Nye H.E., Hiroi N., Carlezon W.A., Nestler E.J. Region-specific induction of deltaFosB by repeated administration of typical versus atypical antipsychotic drugs. Synapse 1999, 33(2):118-128.
    • (1999) Synapse , vol.33 , Issue.2 , pp. 118-128
    • Atkins, J.B.1    Chlan-Fourney, J.2    Nye, H.E.3    Hiroi, N.4    Carlezon, W.A.5    Nestler, E.J.6
  • 4
    • 0027494127 scopus 로고
    • Vacuous jaw movements in rats induced by acute reserpine administration: interactions with different doses of apomorphine
    • Baskin P., Salamone J.D. Vacuous jaw movements in rats induced by acute reserpine administration: interactions with different doses of apomorphine. Pharmacol Biochem Behav 1993, 46(4):793-797.
    • (1993) Pharmacol Biochem Behav , vol.46 , Issue.4 , pp. 793-797
    • Baskin, P.1    Salamone, J.D.2
  • 5
    • 0034906042 scopus 로고    scopus 로고
    • Synchrony of rest tremor in multiple limbs in Parkinson's disease: evidence for mul-tiple oscillators
    • Ben-Pazi H., Bergman H., Goldberg J.A., Giladi N., Hansel D., Reches A., Simon E.S. Synchrony of rest tremor in multiple limbs in Parkinson's disease: evidence for mul-tiple oscillators. J Neural Transm 2001, 108:287-296.
    • (2001) J Neural Transm , vol.108 , pp. 287-296
    • Ben-Pazi, H.1    Bergman, H.2    Goldberg, J.A.3    Giladi, N.4    Hansel, D.5    Reches, A.6    Simon, E.S.7
  • 6
    • 0036929017 scopus 로고    scopus 로고
    • Pathophysiology of Parkinson's disease. From clinical neurology to basic neuroscience and back
    • Bergman H., Deuschl G. Pathophysiology of Parkinson's disease. From clinical neurology to basic neuroscience and back. Mov Disord 2002, 17(Suppl. 3):s28-s40.
    • (2002) Mov Disord , vol.17 , Issue.SUPPL. 3
    • Bergman, H.1    Deuschl, G.2
  • 7
    • 68349155793 scopus 로고    scopus 로고
    • Effects of adenosine A2A antagonist KW-6002 (istradefylline) on pimozide-induced oral tremor and striatal c-Fos expression: comparisons with the muscarinic antagonist tropicamide
    • Betz A.J., Vontell R., Valenta J., Worden L., Sink K.S., Font L., Correa M., Sager T.N., Salamone J.D. Effects of adenosine A2A antagonist KW-6002 (istradefylline) on pimozide-induced oral tremor and striatal c-Fos expression: comparisons with the muscarinic antagonist tropicamide. Neuroscience 2009, 163(1):97-108.
    • (2009) Neuroscience , vol.163 , Issue.1 , pp. 97-108
    • Betz, A.J.1    Vontell, R.2    Valenta, J.3    Worden, L.4    Sink, K.S.5    Font, L.6    Correa, M.7    Sager, T.N.8    Salamone, J.D.9
  • 8
    • 77952541246 scopus 로고    scopus 로고
    • Progression of dopaminergic depletion in a model of MPTP-induced Parkinsonism in non-human primates. An (18)F-DOPA and (11)C-DTBZ PET study
    • Blesa J., Juri C., Collantes M., Peñuelas I., Prieto E., Iglesias E., et al. Progression of dopaminergic depletion in a model of MPTP-induced Parkinsonism in non-human primates. An (18)F-DOPA and (11)C-DTBZ PET study. Neurobiol Dis 2010, 38(3):456-463.
    • (2010) Neurobiol Dis , vol.38 , Issue.3 , pp. 456-463
    • Blesa, J.1    Juri, C.2    Collantes, M.3    Peñuelas, I.4    Prieto, E.5    Iglesias, E.6
  • 9
    • 0036460115 scopus 로고    scopus 로고
    • Differential effects of typical and atypical antipsychotic drugs on striosome and matrix compartments of the striatum
    • Bubser M., Deutch A.Y. Differential effects of typical and atypical antipsychotic drugs on striosome and matrix compartments of the striatum. Eur J Neurosci 2002, 15:713-720.
    • (2002) Eur J Neurosci , vol.15 , pp. 713-720
    • Bubser, M.1    Deutch, A.Y.2
  • 11
    • 84863825952 scopus 로고    scopus 로고
    • Tetrabenazine for the treatment of hyperkinetic movement disorders: a review of the literature
    • Chen J.J., Ondo W.G., Dashtipour K., Swope D.M. Tetrabenazine for the treatment of hyperkinetic movement disorders: a review of the literature. Clin Ther 2012, 34(7):1487-1504.
    • (2012) Clin Ther , vol.34 , Issue.7 , pp. 1487-1504
    • Chen, J.J.1    Ondo, W.G.2    Dashtipour, K.3    Swope, D.M.4
  • 12
    • 56549131041 scopus 로고    scopus 로고
    • Adensosine A2A receptors in Parkinson's disease treatment
    • Cieslak M., Komoszynski M., Wojtczak A. Adensosine A2A receptors in Parkinson's disease treatment. Purinergic Signalling 2008, 4:305-312.
    • (2008) Purinergic Signalling , vol.4 , pp. 305-312
    • Cieslak, M.1    Komoszynski, M.2    Wojtczak, A.3
  • 13
    • 0036711473 scopus 로고    scopus 로고
    • Induction of differential patterns of local cerebral glucose metabolism and immediate-early genes by acute clozapine and haloperidol
    • Cochran S.M., McKerchar C.E., Morris B.J., Pratt J.A. Induction of differential patterns of local cerebral glucose metabolism and immediate-early genes by acute clozapine and haloperidol. Neuropharmacology 2002, 43:394-407.
    • (2002) Neuropharmacology , vol.43 , pp. 394-407
    • Cochran, S.M.1    McKerchar, C.E.2    Morris, B.J.3    Pratt, J.A.4
  • 14
    • 74249086846 scopus 로고    scopus 로고
    • Cholinomimetic-induced tremulous jaw movements are suppressed by the adenosine A2A antagonists MSX-3 and SCH58261, but not the adenosine A1 antagonist DPCPX: possible relevance for drug-induced parkinsonism
    • Collins L.E., Galtieri D.J., Brennum L.T., Sager T.N., Hockemeyer J., Müller C.E., Hinman J.R., Chrobak J.J., Salamone J.D. Cholinomimetic-induced tremulous jaw movements are suppressed by the adenosine A2A antagonists MSX-3 and SCH58261, but not the adenosine A1 antagonist DPCPX: possible relevance for drug-induced parkinsonism. Pharmacol Biochem Behav 2010, 94:561-569.
    • (2010) Pharmacol Biochem Behav , vol.94 , pp. 561-569
    • Collins, L.E.1    Galtieri, D.J.2    Brennum, L.T.3    Sager, T.N.4    Hockemeyer, J.5    Müller, C.E.6    Hinman, J.R.7    Chrobak, J.J.8    Salamone, J.D.9
  • 17
    • 80855123923 scopus 로고    scopus 로고
    • The novel adenosine A2A antagonist Lu AA47070 reverses the motor and motivational effects produced by dopamine D2 receptor blockade
    • Collins L.E., Sager T.N., Sams A.G., Pennarola A., Port R.G., Shahriari M., Salamone J.D. The novel adenosine A2A antagonist Lu AA47070 reverses the motor and motivational effects produced by dopamine D2 receptor blockade. Pharmacol Biochem Behav 2012, 100(3):498-505.
    • (2012) Pharmacol Biochem Behav , vol.100 , Issue.3 , pp. 498-505
    • Collins, L.E.1    Sager, T.N.2    Sams, A.G.3    Pennarola, A.4    Port, R.G.5    Shahriari, M.6    Salamone, J.D.7
  • 18
    • 84856204708 scopus 로고    scopus 로고
    • Pharmacological and physiological characterization of the tremulous jaw movement model of parkinsonian tremor: potential insights into the pathophysiology of tremor
    • Collins-Praino L.E., Paul N.E., Rychalsky K.L., Hinman J.R., Chrobak J.J., Senatus P.B., Salamone J.D. Pharmacological and physiological characterization of the tremulous jaw movement model of parkinsonian tremor: potential insights into the pathophysiology of tremor. Front Syst Neurosci 2011, 5:49.
    • (2011) Front Syst Neurosci , vol.5 , pp. 49
    • Collins-Praino, L.E.1    Paul, N.E.2    Rychalsky, K.L.3    Hinman, J.R.4    Chrobak, J.J.5    Senatus, P.B.6    Salamone, J.D.7
  • 19
    • 84863535868 scopus 로고    scopus 로고
    • Extracellular GABA in globus pallidus increases during the induction of oral tremor by haloperidol but not by muscarinic receptor stimulation
    • Collins-Praino L.E., Podurgiel S.J., Kovner R., Randall P.A., Salamone J.D. Extracellular GABA in globus pallidus increases during the induction of oral tremor by haloperidol but not by muscarinic receptor stimulation. Behav Brain Res 2012, 234:129-135.
    • (2012) Behav Brain Res , vol.234 , pp. 129-135
    • Collins-Praino, L.E.1    Podurgiel, S.J.2    Kovner, R.3    Randall, P.A.4    Salamone, J.D.5
  • 20
    • 84879844751 scopus 로고    scopus 로고
    • Deep brain stimulation of the subthalamic nucleus reverses oral tremor in pharmacological models of parkinsonism: interaction with the effects of adenosine A2A antagonism
    • Collins-Praino L.E., Paul N.E., Ledgard F., Podurgiel S.J., Kovner R., Baqi Y., Müller C.E., Senatus P.B., Salamone J.D. Deep brain stimulation of the subthalamic nucleus reverses oral tremor in pharmacological models of parkinsonism: interaction with the effects of adenosine A2A antagonism. Eur J Neurosci 2013, 38:2183-2191.
    • (2013) Eur J Neurosci , vol.38 , pp. 2183-2191
    • Collins-Praino, L.E.1    Paul, N.E.2    Ledgard, F.3    Podurgiel, S.J.4    Kovner, R.5    Baqi, Y.6    Müller, C.E.7    Senatus, P.B.8    Salamone, J.D.9
  • 21
    • 0346365547 scopus 로고    scopus 로고
    • The adenosine A2A antagonist KF17837 reverses locomotor suppression and tremulous jaw movements induced by haloperidol in rats: possible relevance to parkinsonism
    • Correa M., Wisniecki A., Betz A., Dobson D.R., O'Neill M.F., O'Neill M.J., Salamone J.D. The adenosine A2A antagonist KF17837 reverses locomotor suppression and tremulous jaw movements induced by haloperidol in rats: possible relevance to parkinsonism. Behav Brain Res 2004, 148:47-54.
    • (2004) Behav Brain Res , vol.148 , pp. 47-54
    • Correa, M.1    Wisniecki, A.2    Betz, A.3    Dobson, D.R.4    O'Neill, M.F.5    O'Neill, M.J.6    Salamone, J.D.7
  • 22
    • 0031838949 scopus 로고    scopus 로고
    • Behavioural and electromyographic characterization of the local frequency of tacrine-induced tremulous jaw movements
    • Cousins M.S., Atherton A., Salamone J.D. Behavioural and electromyographic characterization of the local frequency of tacrine-induced tremulous jaw movements. Physiol Behav 1998, 64(2):153-158.
    • (1998) Physiol Behav , vol.64 , Issue.2 , pp. 153-158
    • Cousins, M.S.1    Atherton, A.2    Salamone, J.D.3
  • 23
    • 0030895850 scopus 로고    scopus 로고
    • Tremulous jaw movements induced by the acetylcholinesterase inhibitor tacrine: effects of antiparkinsonian drugs
    • Cousins M.S., Carriero D.L., Salamone J.D. Tremulous jaw movements induced by the acetylcholinesterase inhibitor tacrine: effects of antiparkinsonian drugs. Eur J Pharmacol 1997, 322:137-145.
    • (1997) Eur J Pharmacol , vol.322 , pp. 137-145
    • Cousins, M.S.1    Carriero, D.L.2    Salamone, J.D.3
  • 24
    • 0030042757 scopus 로고    scopus 로고
    • Involvement of ventrolateral striatal dopamine in movement initiation and execution: a microdialysis and behavioral investigation
    • Cousins M.S., Salamone J.D. Involvement of ventrolateral striatal dopamine in movement initiation and execution: a microdialysis and behavioral investigation. Neuroscience 1996, 70:849-859.
    • (1996) Neuroscience , vol.70 , pp. 849-859
    • Cousins, M.S.1    Salamone, J.D.2
  • 25
    • 0014682105 scopus 로고
    • Effect of tetrabenazine on extrapyramidal movement disorders
    • Dalby M.A. Effect of tetrabenazine on extrapyramidal movement disorders. Brit Med J 1969, 2:422-423.
    • (1969) Brit Med J , vol.2 , pp. 422-423
    • Dalby, M.A.1
  • 26
  • 28
    • 0025191503 scopus 로고
    • D2 dopamine receptor antagonists induce fos and related proteins in rat striatal neurons
    • Dragunow M., Robertson G.S., Faull R.L., Robertson H.A., Jansen K. D2 dopamine receptor antagonists induce fos and related proteins in rat striatal neurons. Neuroscience 1990, 37(2):287-294.
    • (1990) Neuroscience , vol.37 , Issue.2 , pp. 287-294
    • Dragunow, M.1    Robertson, G.S.2    Faull, R.L.3    Robertson, H.A.4    Jansen, K.5
  • 29
    • 0029896966 scopus 로고    scopus 로고
    • Distinct pharmacological properties and distribution in neurons and endocrine cells of two isoforms of the human vesicular monoamine transporter
    • Erickson J.D., Schafer M.K., Bonner T.I., Eiden L.E., Weihe E. Distinct pharmacological properties and distribution in neurons and endocrine cells of two isoforms of the human vesicular monoamine transporter. Proc Natl Acad Sci USA 1996, 93(10):5166-5171.
    • (1996) Proc Natl Acad Sci USA , vol.93 , Issue.10 , pp. 5166-5171
    • Erickson, J.D.1    Schafer, M.K.2    Bonner, T.I.3    Eiden, L.E.4    Weihe, E.5
  • 31
    • 0030615062 scopus 로고    scopus 로고
    • Adenosine A2A receptor antagonism potentiates l-DOPA-induced turning behaviour and c-fos expression in 6-hydroxydopamine-lesioned rats
    • Fenu S., Pinna A., Ongini E., Morelli M. Adenosine A2A receptor antagonism potentiates l-DOPA-induced turning behaviour and c-fos expression in 6-hydroxydopamine-lesioned rats. Eur J Pharmacol 1997, 321:143-147.
    • (1997) Eur J Pharmacol , vol.321 , pp. 143-147
    • Fenu, S.1    Pinna, A.2    Ongini, E.3    Morelli, M.4
  • 32
    • 0030861647 scopus 로고    scopus 로고
    • Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia
    • Ferré S., Fredholm B., Morelli M., Popoli P., Fuxe K. Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia. Trends Neurosci 1997, 20(10):482-486.
    • (1997) Trends Neurosci , vol.20 , Issue.10 , pp. 482-486
    • Ferré, S.1    Fredholm, B.2    Morelli, M.3    Popoli, P.4    Fuxe, K.5
  • 35
    • 0023746845 scopus 로고
    • Head, facial, and voice tremor
    • Findley L.J., Gresty M.A. Head, facial, and voice tremor. Adv Neurol 1988, 49:239-253.
    • (1988) Adv Neurol , vol.49 , pp. 239-253
    • Findley, L.J.1    Gresty, M.A.2
  • 36
    • 0019456902 scopus 로고
    • Tremor, the cogwheel phenomenon and clonus in Parkinson's disease
    • Findley L.J., Gresty M.A., Halmagyi G.M. Tremor, the cogwheel phenomenon and clonus in Parkinson's disease. J Neurol 1981, 44:534-546.
    • (1981) J Neurol , vol.44 , pp. 534-546
    • Findley, L.J.1    Gresty, M.A.2    Halmagyi, G.M.3
  • 38
    • 0030860262 scopus 로고    scopus 로고
    • Involvement of pallidal and nigral GABA mechanisms in the generation of tremulous jaw movements in rats
    • Finn M., Mayorga A.J., Conlan A., Salamone J.D. Involvement of pallidal and nigral GABA mechanisms in the generation of tremulous jaw movements in rats. Neuroscience 1997, 80(2):535-544.
    • (1997) Neuroscience , vol.80 , Issue.2 , pp. 535-544
    • Finn, M.1    Mayorga, A.J.2    Conlan, A.3    Salamone, J.D.4
  • 39
    • 39749124177 scopus 로고    scopus 로고
    • Paradoxical aspects of parkinsonian tremor
    • Fishman P.S. Paradoxical aspects of parkinsonian tremor. Mov Disord 2008, 23:168-173.
    • (2008) Mov Disord , vol.23 , pp. 168-173
    • Fishman, P.S.1
  • 40
    • 74549128476 scopus 로고    scopus 로고
    • Tetrabenazine as anti-chorea therapy in Huntington disease: an open-label continuation study
    • Frank S. Tetrabenazine as anti-chorea therapy in Huntington disease: an open-label continuation study. BMC Neurol 2009, 9(62).
    • (2009) BMC Neurol , vol.9 , Issue.62
    • Frank, S.1
  • 42
    • 0034736180 scopus 로고    scopus 로고
    • Pharmacological inactivation of the vesicular monoamine transporter can enhance 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodengeration of midbrain dopaminergic neurons, but not locus coeruleus noradrenergic neurons
    • German D.C., Liang C.L., Manaye K.F., Lane K., Sonsalla P.K. Pharmacological inactivation of the vesicular monoamine transporter can enhance 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodengeration of midbrain dopaminergic neurons, but not locus coeruleus noradrenergic neurons. Neuroscience 2000, 101(4):1063-1069.
    • (2000) Neuroscience , vol.101 , Issue.4 , pp. 1063-1069
    • German, D.C.1    Liang, C.L.2    Manaye, K.F.3    Lane, K.4    Sonsalla, P.K.5
  • 43
    • 77957262796 scopus 로고    scopus 로고
    • Tetrabenazine, a monoamine-depleting drug used in the treatment of hyperkinetic movement disorders
    • Guay D.R. Tetrabenazine, a monoamine-depleting drug used in the treatment of hyperkinetic movement disorders. Am J Geriatr Pharmacother 2010, 8(4):331-373.
    • (2010) Am J Geriatr Pharmacother , vol.8 , Issue.4 , pp. 331-373
    • Guay, D.R.1
  • 44
    • 0032102161 scopus 로고    scopus 로고
    • Motor effects induced by a blockade of adenosine A2A receptors in the caudate-putamen
    • Hauber W., Nagel J., Sauer R., Müller C.E. Motor effects induced by a blockade of adenosine A2A receptors in the caudate-putamen. Neuroreport 1998, 9:1803-1806.
    • (1998) Neuroreport , vol.9 , pp. 1803-1806
    • Hauber, W.1    Nagel, J.2    Sauer, R.3    Müller, C.E.4
  • 45
    • 0035783949 scopus 로고    scopus 로고
    • Catalepsy induced by a blockade of dopamine D1 or D2 receptors was reversed by a concomitant blockade of adenosine A2A receptors in the caudate putamen of rats
    • Hauber W., Neuscheler P., Nagel J., Müller C.E. Catalepsy induced by a blockade of dopamine D1 or D2 receptors was reversed by a concomitant blockade of adenosine A2A receptors in the caudate putamen of rats. Eur J Neurosci 2001, 14:1287-1293.
    • (2001) Eur J Neurosci , vol.14 , pp. 1287-1293
    • Hauber, W.1    Neuscheler, P.2    Nagel, J.3    Müller, C.E.4
  • 46
    • 84870199264 scopus 로고    scopus 로고
    • Cerebral causes and consequences of parkinsonian resting tremor: a tale of two circuits?
    • Helmich R.C., Hallett M., Deuschl G., Toni I., Bloem B.R. Cerebral causes and consequences of parkinsonian resting tremor: a tale of two circuits?. Brain 2012, 135(Pt 11):3206-3226.
    • (2012) Brain , vol.135 , Issue.PART 11 , pp. 3206-3226
    • Helmich, R.C.1    Hallett, M.2    Deuschl, G.3    Toni, I.4    Bloem, B.R.5
  • 47
    • 84865640480 scopus 로고    scopus 로고
    • Adenosine A2A antagonists in Parkinson's disease: what's next?
    • Hickey P., Stacy M. Adenosine A2A antagonists in Parkinson's disease: what's next?. Curr Neurol Neurosci Rep 2012, 12:376-385.
    • (2012) Curr Neurol Neurosci Rep , vol.12 , pp. 376-385
    • Hickey, P.1    Stacy, M.2
  • 48
    • 0029796037 scopus 로고    scopus 로고
    • Atypical and typical neuroleptic treatments induce distinct programs of transcription factor expression in the striatum
    • Hiroi N., Graybiel A.M. Atypical and typical neuroleptic treatments induce distinct programs of transcription factor expression in the striatum. J Comp Neurol 1996, 374:70-83.
    • (1996) J Comp Neurol , vol.374 , pp. 70-83
    • Hiroi, N.1    Graybiel, A.M.2
  • 49
    • 2442520220 scopus 로고    scopus 로고
    • Multigram-scale syntheses, stability, and photoreactions of A2A adenosine receptor antagonists with 8-styrylxanthine structure: potential drugs for Parkinson's disease
    • Hockemeyer J., Burbiel J.C., Müller C.E. Multigram-scale syntheses, stability, and photoreactions of A2A adenosine receptor antagonists with 8-styrylxanthine structure: potential drugs for Parkinson's disease. J Org Chem 2004, 69:3308-3318.
    • (2004) J Org Chem , vol.69 , pp. 3308-3318
    • Hockemeyer, J.1    Burbiel, J.C.2    Müller, C.E.3
  • 50
    • 0025266079 scopus 로고
    • Uniform frequency of parkinsonian resting tremor in the lips, jaw, tongue and index finger
    • Hunker C.J., Abbs J.H. Uniform frequency of parkinsonian resting tremor in the lips, jaw, tongue and index finger. Mov Disord 1990, 5:71-77.
    • (1990) Mov Disord , vol.5 , pp. 71-77
    • Hunker, C.J.1    Abbs, J.H.2
  • 51
    • 12844278764 scopus 로고    scopus 로고
    • Validation of the tremulous jaw movement model for assessment of the motor effects of typical and atypical antipychotics: effects of pimozide (Orap) in rats
    • Ishiwari K., Betz A., Weber S., Felsted J., Salamone J.D. Validation of the tremulous jaw movement model for assessment of the motor effects of typical and atypical antipychotics: effects of pimozide (Orap) in rats. Pharmacol Biochem Behav 2005, 80:351-362.
    • (2005) Pharmacol Biochem Behav , vol.80 , pp. 351-362
    • Ishiwari, K.1    Betz, A.2    Weber, S.3    Felsted, J.4    Salamone, J.D.5
  • 54
    • 21244440664 scopus 로고    scopus 로고
    • Istradefylline, a novel adenosine A2A receptor antagonist, for the treatment of Parkinson's disease
    • Jenner P. Istradefylline, a novel adenosine A2A receptor antagonist, for the treatment of Parkinson's disease. Exp Opin Investig Drugs 2005, 14:729-738.
    • (2005) Exp Opin Investig Drugs , vol.14 , pp. 729-738
    • Jenner, P.1
  • 55
    • 0026335134 scopus 로고
    • Vacuous jaw movements and feeding deficits in rats with ventrolateral striatal dopamine depletion: possible relation to parkinsonian symptoms
    • Jicha G.A., Salamone J.D. Vacuous jaw movements and feeding deficits in rats with ventrolateral striatal dopamine depletion: possible relation to parkinsonian symptoms. J Neurosci 1991, 11:3822-3829.
    • (1991) J Neurosci , vol.11 , pp. 3822-3829
    • Jicha, G.A.1    Salamone, J.D.2
  • 57
    • 0028269378 scopus 로고
    • KF17837: a novel selective adenosine A2A receptor antagonist with anticataleptic activity
    • Kanda T., Shiozaki S., Shimada J., Suzuki F., Nakamura J. KF17837: a novel selective adenosine A2A receptor antagonist with anticataleptic activity. Eur J Pharmacol 1994, 256(3):263-268.
    • (1994) Eur J Pharmacol , vol.256 , Issue.3 , pp. 263-268
    • Kanda, T.1    Shiozaki, S.2    Shimada, J.3    Suzuki, F.4    Nakamura, J.5
  • 58
    • 0027309486 scopus 로고
    • Coexistence of Parkinson's disease and myasthenia gravis: a case report
    • Kao K.P., Kwan S.Y., Lin K.P., Chang Y.C. Coexistence of Parkinson's disease and myasthenia gravis: a case report. Clin Neurol Neurosurg 1993, 95(2):137-139.
    • (1993) Clin Neurol Neurosurg , vol.95 , Issue.2 , pp. 137-139
    • Kao, K.P.1    Kwan, S.Y.2    Lin, K.P.3    Chang, Y.C.4
  • 59
    • 0029008717 scopus 로고
    • D1-D2 dopamine receptor synergy in striatum: effects of intrastriatal infusions of dopamine agonists and antagonists on immediate early gene expression
    • Keefe K.A., Gerfen C.R. D1-D2 dopamine receptor synergy in striatum: effects of intrastriatal infusions of dopamine agonists and antagonists on immediate early gene expression. Neuroscience 1995, 66:903-913.
    • (1995) Neuroscience , vol.66 , pp. 903-913
    • Keefe, K.A.1    Gerfen, C.R.2
  • 60
    • 0024422667 scopus 로고
    • Cholinergic stimulation of the ventrolateral striatum elicits mouth movements in rats: pharmacological and regional specificity
    • Kelley A.E., Bakshi V.P., Delfs J.M., Lang C.G. Cholinergic stimulation of the ventrolateral striatum elicits mouth movements in rats: pharmacological and regional specificity. Psychopharmacology 1989, 99:542-549.
    • (1989) Psychopharmacology , vol.99 , pp. 542-549
    • Kelley, A.E.1    Bakshi, V.P.2    Delfs, J.M.3    Lang, C.G.4
  • 61
    • 0028390876 scopus 로고
    • A pharmacological approach to Alzheimer's disease
    • Keltner N.L. A pharmacological approach to Alzheimer's disease. J Psychosoc Nurs Ment Health Serv 1994, 32:37-39.
    • (1994) J Psychosoc Nurs Ment Health Serv , vol.32 , pp. 37-39
    • Keltner, N.L.1
  • 62
    • 33847694844 scopus 로고    scopus 로고
    • Short-term effects of tetrabenazine on chorea associated with Huntington's disease
    • Kenney C., Hunter C., Davidson A., Jankovic J. Short-term effects of tetrabenazine on chorea associated with Huntington's disease. Mov Disord 2007, 22(1):10-13.
    • (2007) Mov Disord , vol.22 , Issue.1 , pp. 10-13
    • Kenney, C.1    Hunter, C.2    Davidson, A.3    Jankovic, J.4
  • 63
    • 33847731495 scopus 로고    scopus 로고
    • Long-term tolerability of tetrabenazine in the treatment of hyperkinetic movement disorders
    • Kenney C., Hunter C., Jankovic J. Long-term tolerability of tetrabenazine in the treatment of hyperkinetic movement disorders. Mov Disord 2007, 22(2):193-197.
    • (2007) Mov Disord , vol.22 , Issue.2 , pp. 193-197
    • Kenney, C.1    Hunter, C.2    Jankovic, J.3
  • 64
    • 33748969036 scopus 로고    scopus 로고
    • Is history of depression a contraindication to treatment with tetrabenazine?
    • Kenney C., Hunter C., Mejia N., Jankovic J. Is history of depression a contraindication to treatment with tetrabenazine?. Clin Neuropharmacol 2006, 29:259-264.
    • (2006) Clin Neuropharmacol , vol.29 , pp. 259-264
    • Kenney, C.1    Hunter, C.2    Mejia, N.3    Jankovic, J.4
  • 67
    • 0028261604 scopus 로고
    • Clozapine and haloperidol produce a differential pattern of immediate early gene expression in rat caudate-putamen, nucleus accumbens, lateral septum and islands of Calleja
    • MacGibbon G.A., Lawlor P.A., Bravo R., Dragunow M. Clozapine and haloperidol produce a differential pattern of immediate early gene expression in rat caudate-putamen, nucleus accumbens, lateral septum and islands of Calleja. Mol Brain Res 1994, 23(1-2):21-32.
    • (1994) Mol Brain Res , vol.23 , Issue.1-2 , pp. 21-32
    • MacGibbon, G.A.1    Lawlor, P.A.2    Bravo, R.3    Dragunow, M.4
  • 69
    • 0031057232 scopus 로고    scopus 로고
    • Tremulous jaw movements produced by acute tacrine administration: possible relation to parkinsonian side effect
    • Mayorga A.J., Carriero D.L., Cousins M.S., Gianutsos G., Salamone J.D. Tremulous jaw movements produced by acute tacrine administration: possible relation to parkinsonian side effect. Pharmacol Biochem Behav 1997, 56(2):273-279.
    • (1997) Pharmacol Biochem Behav , vol.56 , Issue.2 , pp. 273-279
    • Mayorga, A.J.1    Carriero, D.L.2    Cousins, M.S.3    Gianutsos, G.4    Salamone, J.D.5
  • 71
    • 0021053879 scopus 로고
    • The clinical use of anticholinergic drugs as treatment for extrapyramidal side effects of neuroleptic drugs
    • McEvoy J.P. The clinical use of anticholinergic drugs as treatment for extrapyramidal side effects of neuroleptic drugs. J Clin Psychpharmacol 1983, 3(5):288-302.
    • (1983) J Clin Psychpharmacol , vol.3 , Issue.5 , pp. 288-302
    • McEvoy, J.P.1
  • 73
    • 75749084489 scopus 로고    scopus 로고
    • In vivo measurement of vesicular monoamine transporter type 2 density in Parkinson disease with (18)F-AV-133
    • Okamura N., Villemagne V.L., Drago J., Pejoska S., Dhamija R.K., Mulligan R.S., et al. In vivo measurement of vesicular monoamine transporter type 2 density in Parkinson disease with (18)F-AV-133. J Nucl Med 2010, 51(2):233-238.
    • (2010) J Nucl Med , vol.51 , Issue.2 , pp. 233-238
    • Okamura, N.1    Villemagne, V.L.2    Drago, J.3    Pejoska, S.4    Dhamija, R.K.5    Mulligan, R.S.6
  • 75
    • 0026729474 scopus 로고
    • Exacerbation of parkinsonism by tacrine
    • Ott B.R., Lannon M.C. Exacerbation of parkinsonism by tacrine. Clin Neuropharmacol 1992, 15(4):322-325.
    • (1992) Clin Neuropharmacol , vol.15 , Issue.4 , pp. 322-325
    • Ott, B.R.1    Lannon, M.C.2
  • 76
    • 84876806918 scopus 로고    scopus 로고
    • Effect of subtype-selective adenosine receptor antagonists on basal or haloperidol-regulated striatal function: studies of exploratory locomotion and c-Fos immunoreactivity in outbred and A(2A)R KO mice
    • Pardo M., López-Cruz L., Valverde O., Ledent C., Baqi Y., Müller C.E., Salamone J.D., Correa M. Effect of subtype-selective adenosine receptor antagonists on basal or haloperidol-regulated striatal function: studies of exploratory locomotion and c-Fos immunoreactivity in outbred and A(2A)R KO mice. Behav Brain Res 2013, 247:217-226.
    • (2013) Behav Brain Res , vol.247 , pp. 217-226
    • Pardo, M.1    López-Cruz, L.2    Valverde, O.3    Ledent, C.4    Baqi, Y.5    Müller, C.E.6    Salamone, J.D.7    Correa, M.8
  • 77
    • 0023945855 scopus 로고
    • Depletion of monoamine transmitters by tetrabenzaine in brain tissue in Huntingtons disease
    • Pearson S.J., Reynolds G.P. Depletion of monoamine transmitters by tetrabenzaine in brain tissue in Huntingtons disease. Neuropharmacology 1988, 27(7):717-719.
    • (1988) Neuropharmacology , vol.27 , Issue.7 , pp. 717-719
    • Pearson, S.J.1    Reynolds, G.P.2
  • 78
    • 0021251068 scopus 로고
    • Tetrabenazine-induced depletion of brain monoamines: mechanism by which desmethylimipramine protects cortical norepinephrine
    • Pettibone D.J., Pflueger A.B., Totaro J.A. Tetrabenazine-induced depletion of brain monoamines: mechanism by which desmethylimipramine protects cortical norepinephrine. Eur J Pharmacol 1984, 102:431-436.
    • (1984) Eur J Pharmacol , vol.102 , pp. 431-436
    • Pettibone, D.J.1    Pflueger, A.B.2    Totaro, J.A.3
  • 79
    • 0021251067 scopus 로고
    • Tetrabenazine-induced depletion of brain monoamines: characterization and interaction with selected antidepressants
    • Pettibone D.J., Totaro J.A., Pflueger A.B. Tetrabenazine-induced depletion of brain monoamines: characterization and interaction with selected antidepressants. Eur J Pharmacol 1984, 102:425-430.
    • (1984) Eur J Pharmacol , vol.102 , pp. 425-430
    • Pettibone, D.J.1    Totaro, J.A.2    Pflueger, A.B.3
  • 80
    • 34250647416 scopus 로고    scopus 로고
    • Adenosine A2A receptor antagonists improve deficits in initiation of movement and sensory motor integration in the unilateral 6-hydroxydopamine rat model of Parkinson's disease
    • Pinna A., Pontis S., Borshini F., Morelli M. Adenosine A2A receptor antagonists improve deficits in initiation of movement and sensory motor integration in the unilateral 6-hydroxydopamine rat model of Parkinson's disease. Synapse 2007, 61(8):606-614.
    • (2007) Synapse , vol.61 , Issue.8 , pp. 606-614
    • Pinna, A.1    Pontis, S.2    Borshini, F.3    Morelli, M.4
  • 81
    • 0032589811 scopus 로고    scopus 로고
    • Involvement of adenosine A2A receptors in the induction of c-fos expression by clozapine and haloperidol
    • Pinna A., Wardas J., Cozzolino A., Morelli M. Involvement of adenosine A2A receptors in the induction of c-fos expression by clozapine and haloperidol. Neuropsychopharmacology 1999, 20(1):44-51.
    • (1999) Neuropsychopharmacology , vol.20 , Issue.1 , pp. 44-51
    • Pinna, A.1    Wardas, J.2    Cozzolino, A.3    Morelli, M.4
  • 82
    • 0030610483 scopus 로고    scopus 로고
    • Adenosine A2A receptor agonists increase Fos-like immunoreactivity in mesolimbic areas
    • Pinna A., Wardas J., Cristalli G., Morelli M. Adenosine A2A receptor agonists increase Fos-like immunoreactivity in mesolimbic areas. Brain Res 1997, 759(1):41-49.
    • (1997) Brain Res , vol.759 , Issue.1 , pp. 41-49
    • Pinna, A.1    Wardas, J.2    Cristalli, G.3    Morelli, M.4
  • 83
    • 26244451377 scopus 로고    scopus 로고
    • Muscarinic receptor blockade attenuates reserpine-mediated Fos induction in the rat striatopallidal pathway
    • Pollack A.E., Angerer M.R. Muscarinic receptor blockade attenuates reserpine-mediated Fos induction in the rat striatopallidal pathway. Brain Res 2005, 1058(1-2):189-192.
    • (2005) Brain Res , vol.1058 , Issue.1-2 , pp. 189-192
    • Pollack, A.E.1    Angerer, M.R.2
  • 84
    • 77952899450 scopus 로고    scopus 로고
    • Role of tetrabenazine for Huntington's disease-associated chorea
    • Poon L.H., Kang G.A., Lee A.J. Role of tetrabenazine for Huntington's disease-associated chorea. Ann Pharmacother 2010, 44(6):1080-1089.
    • (2010) Ann Pharmacother , vol.44 , Issue.6 , pp. 1080-1089
    • Poon, L.H.1    Kang, G.A.2    Lee, A.J.3
  • 85
    • 0026616998 scopus 로고
    • D1 and D2 dopamine receptors differentially regulate c-fos expression in striatonigral and striatopallidal neurons
    • Robertson G.S., Vincent S.R., Fibiger H.C. D1 and D2 dopamine receptors differentially regulate c-fos expression in striatonigral and striatopallidal neurons. Neuroscience 1992, 49:285-296.
    • (1992) Neuroscience , vol.49 , pp. 285-296
    • Robertson, G.S.1    Vincent, S.R.2    Fibiger, H.C.3
  • 87
    • 0023891990 scopus 로고
    • Expression of c-fos protein in brain: metabolic mapping at the cellular level
    • Sagar S.M., Sharp F.R., Curran T. Expression of c-fos protein in brain: metabolic mapping at the cellular level. Science 1988, 240:1328-1333.
    • (1988) Science , vol.240 , pp. 1328-1333
    • Sagar, S.M.1    Sharp, F.R.2    Curran, T.3
  • 88
    • 77957728136 scopus 로고    scopus 로고
    • Preladenant, a novel adenosine A(2A) receptor antagonist for the potential treatment of parkinsonism and other disorders
    • Salamone J.D. Preladenant, a novel adenosine A(2A) receptor antagonist for the potential treatment of parkinsonism and other disorders. IDrugs 2010, 13:723-731.
    • (2010) IDrugs , vol.13 , pp. 723-731
    • Salamone, J.D.1
  • 89
    • 0029932120 scopus 로고    scopus 로고
    • Vacuous jaw movements induced by acute reserpine and lowdose apomorphine: possible model of parkinsonism tremor
    • Salamone J., Baskin P. Vacuous jaw movements induced by acute reserpine and lowdose apomorphine: possible model of parkinsonism tremor. Pharmacol Biochem Behav 1996, 53(1):179-183.
    • (1996) Pharmacol Biochem Behav , vol.53 , Issue.1 , pp. 179-183
    • Salamone, J.1    Baskin, P.2
  • 91
    • 9644269028 scopus 로고    scopus 로고
    • Dopamine agonists suppress cholinomimetic-induced tremulous jaw movements in an animal model of parkinsonism: tremerolytic effects of pergolide, ropinirole, and CY 208-243
    • Salamone J.D., Carlson B.B., Rios C., Lentini E., Correa M., Wisniecki A., Betz A. Dopamine agonists suppress cholinomimetic-induced tremulous jaw movements in an animal model of parkinsonism: tremerolytic effects of pergolide, ropinirole, and CY 208-243. Behav Brain Res 2005, 156(2):173-179.
    • (2005) Behav Brain Res , vol.156 , Issue.2 , pp. 173-179
    • Salamone, J.D.1    Carlson, B.B.2    Rios, C.3    Lentini, E.4    Correa, M.5    Wisniecki, A.6    Betz, A.7
  • 92
    • 84882740790 scopus 로고    scopus 로고
    • Conditional neural knockout of the adenosine A2A receptor and pharmacological A2A antagonism reduce pilocarpine-induced tremulous jaw movements: Studies with a mouse model of parkinsonian tremor
    • Salamone JD, Collins-Praino LE, Pardo M, Podurgiel SJ, Baqi Y, Müller CE, Schwarzschild MA, Correa M (2012) Conditional neural knockout of the adenosine A2A receptor and pharmacological A2A antagonism reduce pilocarpine-induced tremulous jaw movements: studies with a mouse model of parkinsonian tremor. Eur Neuropsychopharmacol, in press.
    • (2012) Eur Neuropsychopharmacol
    • Salamone, J.D.1    Collins-Praino, L.E.2    Pardo, M.3    Podurgiel, S.J.4    Baqi, Y.5    Müller, C.E.6    Schwarzschild, M.A.7    Correa, M.8
  • 97
    • 33750990193 scopus 로고    scopus 로고
    • Botulinum toxin A may be efficacious as treatment for jaw tremor in Parkinson's disease
    • Schneider S.A., Edwards M.J., Cordivari C., Macleod W.N., Bhatia K.P. Botulinum toxin A may be efficacious as treatment for jaw tremor in Parkinson's disease. Mov Disord 2006, 21:1722-1724.
    • (2006) Mov Disord , vol.21 , pp. 1722-1724
    • Schneider, S.A.1    Edwards, M.J.2    Cordivari, C.3    Macleod, W.N.4    Bhatia, K.P.5
  • 98
    • 34250325853 scopus 로고    scopus 로고
    • Botulinum toxin in the treatment of tremors, dystonias, sialorrhea and other symptoms associated with Parkinson's disease
    • Sheffield J.K., Jankovic J. Botulinum toxin in the treatment of tremors, dystonias, sialorrhea and other symptoms associated with Parkinson's disease. Expert Rev Neurother 2007, 7:637-647.
    • (2007) Expert Rev Neurother , vol.7 , pp. 637-647
    • Sheffield, J.K.1    Jankovic, J.2
  • 100
    • 3543107307 scopus 로고    scopus 로고
    • Blockade of adenosine A2A receptors antagonizes parkinsonian tremor in the rat tacrine model by an action on specific striatal regions
    • Simola N., Fenu S., Baraldi P.G., Tabrizi M.A., Morelli M. Blockade of adenosine A2A receptors antagonizes parkinsonian tremor in the rat tacrine model by an action on specific striatal regions. Exp Neurol 2004, 189:182-188.
    • (2004) Exp Neurol , vol.189 , pp. 182-188
    • Simola, N.1    Fenu, S.2    Baraldi, P.G.3    Tabrizi, M.A.4    Morelli, M.5
  • 102
    • 0027460640 scopus 로고
    • Vacuous jaw movements induced by subchronic administration of haloperidol: interactions with scopolamine
    • Steinpreis R.E., Baskin P., Salamone J.D. Vacuous jaw movements induced by subchronic administration of haloperidol: interactions with scopolamine. Psychopharmacology 1993, 111(1):99-105.
    • (1993) Psychopharmacology , vol.111 , Issue.1 , pp. 99-105
    • Steinpreis, R.E.1    Baskin, P.2    Salamone, J.D.3
  • 103
    • 0029123860 scopus 로고
    • TJS-010, a new prescription of oriental medicine, antagonizes tetrabenazine-induced suppression of spontaneous locomotor activity in rats
    • Tanra A.J., Kagaya A., Okamoto Y., Muraoka M., Motohashi N., Yamawaki S. TJS-010, a new prescription of oriental medicine, antagonizes tetrabenazine-induced suppression of spontaneous locomotor activity in rats. Prog Neuropsychopharmacol Biol Psychiatry 1995, 19(5):963-971.
    • (1995) Prog Neuropsychopharmacol Biol Psychiatry , vol.19 , Issue.5 , pp. 963-971
    • Tanra, A.J.1    Kagaya, A.2    Okamoto, Y.3    Muraoka, M.4    Motohashi, N.5    Yamawaki, S.6
  • 104
    • 0021036038 scopus 로고
    • Neuroleptic-induced extrapyramidal reactions: classification, description and diagnosis
    • Tarsy D. Neuroleptic-induced extrapyramidal reactions: classification, description and diagnosis. Clin Neuropharmacol 1983, 6:s9-s26.
    • (1983) Clin Neuropharmacol , vol.6
    • Tarsy, D.1
  • 105
    • 0029056219 scopus 로고
    • Regional distribution of monoamine vesicular uptake sites in the mesencephalon of control subjects and patients with Parkinson's disease: a postmortem study using tritiated tetrabenazine
    • Thibaut F., Faucheux B.A., Marquez J., Villares J., Menard J.F., Agid Y., Hirsch E.C. Regional distribution of monoamine vesicular uptake sites in the mesencephalon of control subjects and patients with Parkinson's disease: a postmortem study using tritiated tetrabenazine. Brain Res 1995, 692(1-2):233-243.
    • (1995) Brain Res , vol.692 , Issue.1-2 , pp. 233-243
    • Thibaut, F.1    Faucheux, B.A.2    Marquez, J.3    Villares, J.4    Menard, J.F.5    Agid, Y.6    Hirsch, E.C.7
  • 106
    • 52249123447 scopus 로고    scopus 로고
    • Dopamine modulating drugs influence striatal (+)-[11C]DTBZ binding in rats: VMAT2 binding is sensitive to changes in vesicular dopamine concentration
    • Tong J., Wilson A.A., Boileau I., Houle S., Kish S.J. Dopamine modulating drugs influence striatal (+)-[11C]DTBZ binding in rats: VMAT2 binding is sensitive to changes in vesicular dopamine concentration. Synapse 2008, 62(11):873-876.
    • (2008) Synapse , vol.62 , Issue.11 , pp. 873-876
    • Tong, J.1    Wilson, A.A.2    Boileau, I.3    Houle, S.4    Kish, S.J.5
  • 107
    • 0026788225 scopus 로고
    • Synaptic organization of GABAergic inputs from the striatum and the globus pallidus onto neurons in the substantia nigra and retrorubral field which project to the medullary reticular formation
    • von Krosigk M., Smith Y., Bolam J.P., Smith A.D. Synaptic organization of GABAergic inputs from the striatum and the globus pallidus onto neurons in the substantia nigra and retrorubral field which project to the medullary reticular formation. Neuroscience 1992, 50:531-549.
    • (1992) Neuroscience , vol.50 , pp. 531-549
    • von Krosigk, M.1    Smith, Y.2    Bolam, J.P.3    Smith, A.D.4
  • 108
    • 77952511883 scopus 로고    scopus 로고
    • In vivo studies of the SERT-selective [18F]FPBM and VMAT2-selective [18F]AV-133 radiotracers in a rat model of Parkinson's disease
    • Wang J.L., Oya S., Parhi A.K., Lieberman B.P., Ploessl K., Hou C., Kung H.F. In vivo studies of the SERT-selective [18F]FPBM and VMAT2-selective [18F]AV-133 radiotracers in a rat model of Parkinson's disease. Nucl Med Biol 2010, 37(4):479-486.
    • (2010) Nucl Med Biol , vol.37 , Issue.4 , pp. 479-486
    • Wang, J.L.1    Oya, S.2    Parhi, A.K.3    Lieberman, B.P.4    Ploessl, K.5    Hou, C.6    Kung, H.F.7
  • 109
    • 0018848495 scopus 로고
    • Physostigmine test in the rabbit syndrome and tardive dyskinesia
    • Weiss K.J., Ciraulo D.A., Shader R.I. Physostigmine test in the rabbit syndrome and tardive dyskinesia. Am J Psychiat 1980, 137:627-628.
    • (1980) Am J Psychiat , vol.137 , pp. 627-628
    • Weiss, K.J.1    Ciraulo, D.A.2    Shader, R.I.3
  • 110
    • 0242576501 scopus 로고    scopus 로고
    • Motor effects of GABAA antagonism in globus palidus: studies of locomotion and tremulous jaw movements
    • Wisniecki A., Correa M., Arizzi M.N., Ishiwari K., Salamone J.D. Motor effects of GABAA antagonism in globus palidus: studies of locomotion and tremulous jaw movements. Psychopharmacology 2003, 170:140-149.
    • (2003) Psychopharmacology , vol.170 , pp. 140-149
    • Wisniecki, A.1    Correa, M.2    Arizzi, M.N.3    Ishiwari, K.4    Salamone, J.D.5
  • 111
    • 0022002171 scopus 로고
    • The effect of different types of cortical lesions on drug-induced catalepsy in rats: a pharmacological analysis
    • Worms P., Willigens M.T., Continsouza-Blanc D., Lloyd K.G. The effect of different types of cortical lesions on drug-induced catalepsy in rats: a pharmacological analysis. Eur J Pharmacol 1985, 113(1):53-59.
    • (1985) Eur J Pharmacol , vol.113 , Issue.1 , pp. 53-59
    • Worms, P.1    Willigens, M.T.2    Continsouza-Blanc, D.3    Lloyd, K.G.4
  • 112
    • 0033060133 scopus 로고    scopus 로고
    • Clozapine pretreatment modifies haloperidol-elicited forebrain Fos induction: a regionally-specific double dissociation
    • Young C.D., Bubser M., Meltzer H.Y., Deutch A.Y. Clozapine pretreatment modifies haloperidol-elicited forebrain Fos induction: a regionally-specific double dissociation. Psychopharmacology 1999, 144(3):255-263.
    • (1999) Psychopharmacology , vol.144 , Issue.3 , pp. 255-263
    • Young, C.D.1    Bubser, M.2    Meltzer, H.Y.3    Deutch, A.Y.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.